Literature DB >> 15580541

Homeostatic model assessment and risk for hypertension during pregnancy: a longitudinal prospective study.

Gustavo Romero-Gutiérrez1, Juan Manuel Malacara, Norma Amador, César Fierro-Martínez, Luis Manuel Muñoz-Guevara, Roberto Molina-Rodríguez.   

Abstract

The purpose of this study was to determine the association between insulin resistance and hypertension during pregnancy with the homeostatic model assessment (HOMA-IR). A longitudinal prospective study was carried out. One hundred sixty normotensive pregnant women were followed from the first trimester until delivery. HOMA-IR levels were determined each trimester. Statistical analysis included one-way analysis of variance and multivariate logistic regression. At follow-up, 134 women (83.8%) remained normotensive, 18 (11.2%) developed gestational hypertension, and 8 (5%) developed preeclampsia. At first trimester, HOMA-IR levels were higher in women who developed gestational hypertension (2.1 +/- 0.2) than in women who developed preeclampsia (1.2 +/- 0.0), or remained normotensive (1.2 +/- 0.3); p < 0.01. In the logistic regression analysis, HOMA-IR levels at first trimester were statistically significant ( p = 0.03) to predict development of gestational hypertension. Our results support the use of the HOMA-IR as an alternative index for the assessment of the risk for hypertension during pregnancy.

Entities:  

Mesh:

Year:  2004        PMID: 15580541     DOI: 10.1055/s-2004-835962

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  2 in total

Review 1.  Current model systems for the study of preeclampsia.

Authors:  M L Martinez-Fierro; G P Hernández-Delgadillo; V Flores-Morales; E Cardenas-Vargas; M Mercado-Reyes; I P Rodriguez-Sanchez; I Delgado-Enciso; C E Galván-Tejada; J I Galván-Tejada; J M Celaya-Padilla; I Garza-Veloz
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-07

2.  Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin.

Authors:  Jyoti Balani; Steve Hyer; Argyro Syngelaki; Ranjit Akolekar; Kypros H Nicolaides; Antoinette Johnson; Hassan Shehata
Journal:  Obstet Med       Date:  2017-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.